PMID- 24606089 OWN - NLM STAT- MEDLINE DCOM- 20140808 LR - 20171116 IS - 1945-7197 (Electronic) IS - 0021-972X (Linking) VI - 99 IP - 6 DP - 2014 Jun TI - The metabolically healthy but obese phenotype is associated with lower plasma levels of persistent organic pollutants as compared to the metabolically abnormal obese phenotype. PG - E1061-6 LID - 10.1210/jc.2013-3935 [doi] AB - CONTEXT: Although obesity is strongly linked to insulin resistance and type 2 diabetes, a subset of obese individuals termed metabolically healthy but obese (MHO) appears relatively protected from the development of cardiometabolic complications. The origins of this metabolically healthy phenotype remain unclear. Recently, persistent organic pollutants (POPs) have emerged as potential endocrine disruptors. OBJECTIVE: The aim of this study was to test the hypothesis that the MHO phenotype presents lower circulating levels of POPs as compared to the metabolically abnormal obese (MAO) phenotype. DESIGN, SETTING, AND PATIENTS: We conducted a cross-sectional study of 76 nondiabetic obese (body mass index >/=30 kg/m(2)) postmenopausal women. MAIN OUTCOME MEASURES: Plasma concentrations of 21 POPs as well as cardiometabolic risk factors were analyzed. RESULTS: For similar age, body mass index, and fat mass index, MHO women (n = 40) showed higher insulin sensitivity levels and a more favorable cardiometabolic profile than MAO women (n = 36), as evidenced by a 2-fold increase in glucose disposal rates measured by the hyperinsulinemic-euglycemic clamp (P = .001). Among 18 detectable pollutants measured, MAO women had higher plasma concentrations of 12 POPs (fold increase, 1.4-2.9; P < .001-.036). Logistic regression analyses showed that the prevalence of the MAO phenotype was significantly associated with higher levels of total dioxin- and non-dioxin-like polychlorinated biphenyls (odds ratio, 4.7; 95% confidence interval, 1.8-12.5; P = .002), as well as trans-nonachlor (odds ratio, 6.1; 95% CI, 2.2-16.4; P < .001). CONCLUSION: Our study demonstrates that the metabolically healthy and abnormal phenotypes have distinct plasma POP profiles. FAU - Gauthier, Marie-Soleil AU - Gauthier MS AD - Institut de Recherches Cliniques de Montreal (M.-S.G., R.R.-L.), Montreal, Quebec, H2W 1R7, Canada; Montreal Diabetes Research Centre at the Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM) (M.-S.G., R.R.-L.) Montreal, Quebec, H1W 4A4, Canada; The Nutrition Department (R.R.-L.), Universite de Montreal; the Endocrinology Division (R.R.-L.), Montreal University Hospital, Montreal, Quebec, Canada H2W 1T8; School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, K1N 6N5, Canada; Institut de Recherche de l'Hopital Montfort (D.P.), Ottawa, Ontario, K1K 0T2, Canada; Department of Kinanthropology (A.K.), Universite du Quebec a Montreal, Montreal, Quebec, Canada H3C 3P8; MTM Research Center (D.G., B.v.B.), School of Science and Technology, Orebro University, SE-701 82 Orebro, Sweden; and Department of Biology (J.R.), University of Bergen, N-5006 Bergen, Norway. FAU - Rabasa-Lhoret, Remi AU - Rabasa-Lhoret R FAU - Prud'homme, Denis AU - Prud'homme D FAU - Karelis, Antony D AU - Karelis AD FAU - Geng, Dawei AU - Geng D FAU - van Bavel, Bert AU - van Bavel B FAU - Ruzzin, Jerome AU - Ruzzin J LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140225 PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (Environmental Pollutants) RN - 0 (Organic Chemicals) SB - IM CIN - J Clin Endocrinol Metab. 2014 Jun;99(6):1993-4. PMID: 24893136 MH - Aged MH - *Body Mass Index MH - Cardiovascular Diseases/epidemiology/etiology MH - Environmental Pollutants/*blood MH - Female MH - Health MH - Humans MH - Metabolic Syndrome/epidemiology/etiology MH - Middle Aged MH - Obesity/blood/complications/epidemiology/*metabolism MH - Organic Chemicals/*blood MH - Overweight/blood/complications/epidemiology MH - Phenotype MH - Risk Factors EDAT- 2014/03/13 06:00 MHDA- 2014/08/13 06:00 CRDT- 2014/03/11 06:00 PHST- 2014/03/11 06:00 [entrez] PHST- 2014/03/13 06:00 [pubmed] PHST- 2014/08/13 06:00 [medline] AID - 10.1210/jc.2013-3935 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 2014 Jun;99(6):E1061-6. doi: 10.1210/jc.2013-3935. Epub 2014 Feb 25.